Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

833 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.
Infante JR, Somer BG, Park JO, Li CP, Scheulen ME, Kasubhai SM, Oh DY, Liu Y, Redhu S, Steplewski K, Le N. Infante JR, et al. Among authors: li cp. Eur J Cancer. 2014 Aug;50(12):2072-81. doi: 10.1016/j.ejca.2014.04.024. Epub 2014 Jun 7. Eur J Cancer. 2014. PMID: 24915778 Clinical Trial.
Gemcitabine causes telomere attrition by stabilizing TRF2.
Su CH, Chu WC, Lan KH, Li CP, Chao Y, Lin HC, Lee SD, Tsai YC, Lee WP. Su CH, et al. Among authors: li cp. Eur J Cancer. 2012 Dec;48(18):3465-74. doi: 10.1016/j.ejca.2012.04.015. Epub 2012 Jun 14. Eur J Cancer. 2012. PMID: 22704123
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy.
Kim YH, Muro K, Yasui H, Chen JS, Ryu MH, Park SH, Chu KM, Choo SP, Sanchez T, DelaCruz C, Mukhopadhyay P, Lainas I, Li CP. Kim YH, et al. Among authors: li cp. Cancer Chemother Pharmacol. 2012 Oct;70(4):583-90. doi: 10.1007/s00280-012-1943-6. Epub 2012 Aug 12. Cancer Chemother Pharmacol. 2012. PMID: 22886073 Free PMC article. Clinical Trial.
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.
Chao Y, Hsieh JS, Yeh HT, Su YC, Wu CC, Chen JS, Tai CJ, Bai LY, Yeh KH, Su WC, Li CP. Chao Y, et al. Among authors: li cp. Cancer Chemother Pharmacol. 2014 Apr;73(4):799-806. doi: 10.1007/s00280-014-2407-y. Epub 2014 Feb 17. Cancer Chemother Pharmacol. 2014. PMID: 24531611 Free PMC article. Clinical Trial.
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.
Chen JS, Hsu C, Chiang NJ, Tsai CS, Tsou HH, Huang SF, Bai LY, Chang IC, Shiah HS, Ho CL, Yen CJ, Lee KD, Chiu CF, Rau KM, Yu MS, Yang Y, Hsieh RK, Chang JY, Shan YS, Chao Y, Chen LT; Taiwan Cooperative Oncology Group. Chen JS, et al. Ann Oncol. 2015 May;26(5):943-949. doi: 10.1093/annonc/mdv035. Epub 2015 Jan 28. Ann Oncol. 2015. PMID: 25632066 Free article. Clinical Trial.
833 results